Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oz crop pty ltd - clethodim; liquid hydrocarbon - emulsifiable concentrate - clethodim cyclohexanediones active 360.0 g/l; liquid hydrocarbon solvent other 570.0 g/l - herbicide

Australia - English - Department of Health (Therapeutic Goods Administration)

cordis australia pty ltd - 36035 - prosthesis, internal, stent, vascular - a cordis pta balloon catheter is used as a delivery system for the palmaz genesis peripheral stent. the delivery system utilizes an over-the-wire design and is a catheter with a balloon and a proximal y-connector. two radiopaque marker bands aid in stent placement.the injectate lumen is used to inject contrast medium via hand injection, and to track the catheter over a guidewire. the inflation lumen is used to inflate and deflate the balloon. the cordis palmaz genesis peripheral stent on opta pro .035" delivery system is intended for use in the treatment of atherosclerotic disease of peripheral arteries below the aortic arch and for palliation of malignant neoplasms in the biliary tree.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - clethodim; liquid hydrocarbon - emulsifiable concentrate - clethodim cyclohexanediones active 240.0 g/l; liquid hydrocarbon solvent other 630.0 g/l - herbicide - adzuki bean | beetroot | broad bean | cabbage | canola | celery | chickpea | cotton | faba bean | field pea | forestry | lentil - annual phalaris | annual ryegrass | barley grass | barnyard grass or water grass | blown grass | brome grass | crowsfoot grass | feathertop rhodes grass | johnson grass - seedling | liverseed or urochloa grass | paradoxa grass | red sprangletop grass | silver grass (v.bromoides) - suppression | silver grass or rat's-tail fescue | summer grass | volunteer barley | volunteer oat | volunteer sorghum | volunteer wheat | wild oat | winter grass | annual blue grass | annual phalaris | annual poa | bromus diandrus | bromus rigidus | canary grass | common oats | crab grass | festuca myuros | goose grass | h. hexastichon | hairy rhodes grass | liverseed grass | native rhodes grass | triticum aestivum | vulpia myuros | vulpia spp. | woollytop rhodes grass

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - risperidone, quantity: 4 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; indigo carmine aluminium lake; lactose monohydrate; quinoline yellow; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 4000 - treatment of schizophrenia and related psychoses. short-term treatment of acute mania associated with bipolar i disorder. treatment of behavioural disturbances in dementia. treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see clinical trials for maintenance data). treatment of behavioural disorders associated with autism in children and adolescents (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - risperidone, quantity: 3 mg - tablet, film coated - excipient ingredients: quinoline yellow; lactose monohydrate; magnesium stearate; pregelatinised maize starch; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 4000 - treatment of schizophrenia and related psychoses. short-term treatment of acute mania associated with bipolar i disorder. treatment of behavioural disturbances in dementia. treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see clinical trials for maintenance data). treatment of behavioural disorders associated with autism in children and adolescents (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - risperidone, quantity: 2 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; iron oxide yellow; iron oxide red; lactose monohydrate; titanium dioxide; hypromellose; macrogol 4000 - treatment of schizophrenia and related psychoses. short-term treatment of acute mania associated with bipolar i disorder. treatment of behavioural disturbances in dementia. treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see clinical trials for maintenance data). treatment of behavioural disorders associated with autism in children and adolescents (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - risperidone, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; pregelatinised maize starch; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 4000 - treatment of schizophrenia and related psychoses. short-term treatment of acute mania associated with bipolar i disorder. treatment of behavioural disturbances in dementia. treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see clinical trials for maintenance data). treatment of behavioural disorders associated with autism in children and adolescents (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - risperidone, quantity: 0.5 mg - tablet, film coated - excipient ingredients: titanium dioxide; stearic acid; microcrystalline cellulose; iron oxide red; hypromellose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate - treatment of schizophrenia and related psychoses. short-term treatment of acute mania associated with bipolar i disorder. treatment of behavioural disturbances in dementia. treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see clinical trials for maintenance data). treatment of behavioural disorders associated with autism in children and adolescents (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

genesis airway innovations pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

genesis airway innovations pty ltd -